Oak Ridge Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Oak Ridge Investments’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-181,392	Closed	-$7.35M	–	141
2016 Q1	$7.35M	Buy	181,392 +3,644	+2%	+$148K	0.19%	98
2015 Q4	$11M	Sell	177,748 -1,292	-0.7%	-$69.7K	0.26%	89
2015 Q3	$7.24M	Sell	179,040 -524	-0.3%	-$27.1K	0.17%	106
2015 Q2	$10.3M	Sell	179,564 -944	-0.5%	-$60K	0.22%	99
2015 Q1	$11.5M	Sell	180,508 -193	-0.1%	-$13.1K	0.26%	95
2014 Q4	$11.2M	Buy	+180,701	New	+$8.92M	0.27%	92

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Oak Ridge Investments's IONS Position: Q2 2016 in Review

Oak Ridge Investments sold out of Ionis Pharmaceuticals (IONS) in Q2 2016, closing a stake of 181,392 shares — an estimated $7.35M sold.

Oak Ridge Investments first reported a position in IONS in Q4 2014 and held it in 6 quarters. The position peaked at $11.5M in Q1 2015. 282 funds tracked by Wall St. Rank hold IONS as of Q2 2016.

Oak Ridge Investments reported no remaining Ionis Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Oak Ridge Investments sold 181,392 Ionis Pharmaceuticals shares in Q2 2016, an estimated $7.35M.
Oak Ridge Investments first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 6 quarters.
Oak Ridge Investments's Ionis Pharmaceuticals position peaked at $11.5M in Q1 2015.
282 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2016.

Based on Oak Ridge Investments's 13F filing for Q2 2016, filed 4 Aug 2016.